[1] |
CHEN Jie, WANG Yan, ZHANG Weimin, ZHAO Di, ZHANG Lingyuan, ZHAN Qimin.
Hypoxia induces expression of IL-7 in esophageal squamous cell carcinoma to promote tumor progression
[J]. China Oncology, 2021, 31(5): 361-367.
|
[2] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[3] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[4] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[5] |
HE Hesheng , YANG Yuqiong , LIU Yinhua , JIN Xiaoke , XU Youhai , YAO Junping , LIU Shanhao , YAN Jiawei , HUANG Dongping .
Characteristic analysis of peripheral T-cell lymphoma associated with autoimmune hemolytic anemia
[J]. China Oncology, 2021, 31(2): 121-125.
|
[6] |
LI Lei , WANG Zhi , YOU Chunyuan .
The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report
[J]. China Oncology, 2021, 31(2): 156-160.
|
[7] |
ZHANG Jinzhong , LI Yueqi , SHI Ke , YANG Liang , GUO Dan .
Expression and clinical significance of PLK4 gene in esophageal squamous cell carcinoma and its effect on cell proliferation, invasion and migration
[J]. China Oncology, 2021, 31(12): 1185-1193.
|
[8] |
LI Panpan, ZHANG Zhuo.
Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma
[J]. China Oncology, 2021, 31(12): 1194-1201.
|
[9] |
YU Yi, CONG Qing, XU Congjian, JIANG Wei.
The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism
[J]. China Oncology, 2021, 31(11): 1063-1071.
|
[10] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[11] |
FENG Bo, WANG Gaoyan, LIANG Xiaoliang, WU Zheng, GUO Yanli, SHEN Supeng, GUO Wei.
The expression level of FAM83H in esophageal squamous cell carcinoma and its effect on biological characteristics of esophageal cancer cells
[J]. China Oncology, 2020, 30(9): 674-681.
|
[12] |
ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang .
Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer
[J]. China Oncology, 2020, 30(7): 519-524.
|
[13] |
WU Jingwen, YU Xuejuan, YANG Qiu’an.
Association between Onodera’s prognostic nutrition index and adverse effects of concurrent chemoradiotherapy for esophageal squamous cell carcinoma
[J]. China Oncology, 2020, 30(7): 525-530.
|
[14] |
YIN Caiqiao , FANG Chengxiang , CHEN Ting , HUANG Hui , ZHENG Yi , TAN Jiawu , ZHANG Jiqiao , ZHANG Hui .
miR-203a-3p inhibits cell proliferation and invasion of esophageal squamous cell carcinoma by targeting GATA6
[J]. China Oncology, 2020, 30(6): 441-448.
|
[15] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|